{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T02:32:28Z","timestamp":1777170748442,"version":"3.51.4"},"reference-count":34,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.anai.2023.06.026","type":"journal-article","created":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T21:10:21Z","timestamp":1688505021000},"page":"474-481.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Intranasal steroid use and COVID-19 mortality among patients with asthma and COPD"],"prefix":"10.1016","volume":"131","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8544-1483","authenticated-orcid":false,"given":"Virginia","family":"Hernandez Santiago","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adeniyi Francis","family":"Fagbamigbe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank M","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Utkarsh","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Morales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colin","family":"McCowan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Lipworth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.anai.2023.06.026_bib0001","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A Novel Coronavirus from Patients with Pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.anai.2023.06.026_bib0002","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1111\/all.14289","article-title":"Eleven faces of coronavirus disease 2019","volume":"75","author":"Dong","year":"2020","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.anai.2023.06.026_bib0003","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jaci.2020.05.008","article-title":"Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19","volume":"146","author":"Herold","year":"2020","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2023.06.026_bib0004","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S2213-2600(19)30417-5","article-title":"Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial","volume":"8","author":"Villar","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"8","key":"10.1016\/j.anai.2023.06.026_bib0005","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in Hospitalized Patients with Covid-19","volume":"384","author":"Horby","year":"2021","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.anai.2023.06.026_bib0006","first-page":"e55","article-title":"Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial","volume":"9","author":"Ramakrishnan","year":"2021","journal-title":"Lancet Respir Med"},{"issue":"10303","key":"10.1016\/j.anai.2023.06.026_bib0007","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0140-6736(21)01744-X","article-title":"Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial","volume":"398","author":"Yu","year":"2021","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.anai.2023.06.026_bib0008","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1183\/09031936.00015512","article-title":"Differences between asthmatics and nonasthmatics hospitalised with influenza A infection","volume":"41","author":"Myles","year":"2013","journal-title":"Eur Respir J"},{"issue":"7","key":"10.1016\/j.anai.2023.06.026_bib0009","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S2213-2600(21)00013-8","article-title":"Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK","volume":"9","author":"Bloom","year":"2021","journal-title":"Lancet Respir Med"},{"issue":"11","key":"10.1016\/j.anai.2023.06.026_bib0010","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/S2213-2600(20)30415-X","article-title":"Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: an observational cohort study using the OpenSAFELY platform","volume":"8","author":"Schultze","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"7821","key":"10.1016\/j.anai.2023.06.026_bib0011","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","article-title":"Factors associated with COVID-19-related death using OpenSAFELY","volume":"584","author":"Williamson","year":"2020","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.anai.2023.06.026_bib0012","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1056\/NEJMc2001737","article-title":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients","volume":"382","author":"Zou","year":"2020","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.anai.2023.06.026_bib0013","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"issue":"23","key":"10.1016\/j.anai.2023.06.026_bib0014","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1001\/jama.2020.8707","article-title":"Nasal gene expression of angiotensin-converting enzyme 2 in children and adults","volume":"323","author":"Bunyavanich","year":"2020","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.anai.2023.06.026_bib0015","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jaci.2020.04.009","article-title":"Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2","volume":"146","author":"Jackson","year":"2020","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2023.06.026_bib0016","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.jaci.2020.06.038","article-title":"COVID-19: start with the nose","volume":"146","author":"Lipworth","year":"2020","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2023.06.026_bib0017","first-page":"81","article-title":"Relationship between asthma and rhinitis: epidemiologic, pathophysiologic, and therapeutic aspects","volume":"1","author":"Bergeron","year":"2005","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2023.06.026_bib0018","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jaci.2003.11.034","article-title":"Rhinitis therapy and the prevention of hospital care for asthma: a case-control study","volume":"113","author":"Corren","year":"2004","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.anai.2023.06.026_bib0019","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1067\/mai.2002.123237","article-title":"Intranasal steroids and the risk of emergency department visits for asthma","volume":"109","author":"Adams","year":"2002","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2023.06.026_bib0020","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/all.12124","article-title":"Impact of intranasal corticosteroids on asthma outcomes in allergic rhinitis: a meta-analysis","volume":"68","author":"Lohia","year":"2013","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.anai.2023.06.026_bib0021","doi-asserted-by":"crossref","first-page":"106","DOI":"10.2500\/aap.2022.43.210116","article-title":"Clinical effects of intranasal corticosteroids on nasal symptoms in subjects with chronic rhinitis during COVID-19","volume":"43","author":"Tuzer","year":"2022","journal-title":"Allergy Asthma Proc"},{"issue":"4","key":"10.1016\/j.anai.2023.06.026_bib0022","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.anai.2020.07.012","article-title":"Atopy is predictive of a decreased need for hospitalization for coronavirus disease 2019","volume":"125","author":"Keswani","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"10.1016\/j.anai.2023.06.026_bib0023","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1164\/rccm.202107-1704OC","article-title":"Asthma phenotypes and COVID-19 risk: a population-based observational study","volume":"205","author":"Bloom","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.anai.2023.06.026_bib0024","first-page":"162","article-title":"Deprivation and health in Scotland","volume":"48","author":"Carstairs","year":"1990","journal-title":"Health Bull (Edinb)"},{"key":"10.1016\/j.anai.2023.06.026_bib0025","unstructured":"Public Health Scotland. The Scottish Index of Multiple Deprivation. Available at: https:\/\/www.isdscotland.org\/products-and-services\/gpd-support\/deprivation\/simd\/. Accessed June 1, 2023."},{"issue":"11","key":"10.1016\/j.anai.2023.06.026_bib0026","doi-asserted-by":"crossref","first-page":"3934","DOI":"10.1016\/j.jaip.2021.08.007","article-title":"Intranasal corticosteroids are associated with better outcomes in coronavirus disease 2019","volume":"9","author":"Strauss","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"11","key":"10.1016\/j.anai.2023.06.026_bib0027","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.1016\/j.jaip.2021.08.025","article-title":"Corticosteroid protection against COVID-19: begin with the nose","volume":"9","author":"Lipworth","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.anai.2023.06.026_bib0028","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.jaip.2020.12.033","article-title":"Type 2 asthma inflammation and COVID-19: a double edged sword","volume":"9","author":"Lipworth","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.anai.2023.06.026_bib0029","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s00228-007-0286-4","article-title":"Identification of asthmatic children using prescription data and diagnosis","volume":"63","author":"Moth","year":"2007","journal-title":"Eur J Clin Pharmacol"},{"issue":"472","key":"10.1016\/j.anai.2023.06.026_bib0030","first-page":"879","article-title":"The predictive value of asthma medications to identify individuals with asthma\u2013a study in German general practices","volume":"51","author":"Himmel","year":"2001","journal-title":"Br J Gen Pract"},{"issue":"4","key":"10.1016\/j.anai.2023.06.026_bib0031","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s10096-020-04078-1","article-title":"High versus standard doses of corticosteroids in severe COVID-19: a retrospective cohort study","volume":"40","author":"Monreal","year":"2021","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"11","key":"10.1016\/j.anai.2023.06.026_bib0032","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1007\/s00134-020-06223-y","article-title":"The ten reasons why corticosteroid therapy reduces mortality in severe COVID-19","volume":"46","author":"Arabi","year":"2020","journal-title":"Intensive Care Med"},{"issue":"Suppl 9","key":"10.1016\/j.anai.2023.06.026_bib0033","doi-asserted-by":"crossref","first-page":"S1070","DOI":"10.21037\/jtd.2018.04.35","article-title":"Steroids for sepsis: yes, no or maybe","volume":"10","author":"Marik","year":"2018","journal-title":"J Thorac Dis"},{"issue":"10","key":"10.1016\/j.anai.2023.06.026_bib0034","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1111\/all.14302","article-title":"Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: an ARIA-EAACI statement","volume":"75","author":"Bousquet","year":"2020","journal-title":"Allergy"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120623004878?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120623004878?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:32:36Z","timestamp":1761053556000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120623004878"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S1081120623004878"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2023.06.026","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intranasal steroid use and COVID-19 mortality among patients with asthma and COPD","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2023.06.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}